These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23555257)

  • 21. Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
    Tong Y; Zhu Y; Xia X; Liu Y; Feng Y; Hua X; Chen Z; Ding H; Gao L; Wang Y; Feitelson MA; Zhao P; Qi ZT
    J Virol; 2011 Mar; 85(6):2793-802. PubMed ID: 21177818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cell polarization on hepatitis C virus entry.
    Mee CJ; Grove J; Harris HJ; Hu K; Balfe P; McKeating JA
    J Virol; 2008 Jan; 82(1):461-70. PubMed ID: 17959672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occludin-Knockout Human Hepatic Huh7.5.1-8-Derived Cells Are Completely Resistant to Hepatitis C Virus Infection.
    Shirasago Y; Shimizu Y; Tanida I; Suzuki T; Suzuki R; Sugiyama K; Wakita T; Hanada K; Yagi K; Kondoh M; Fukasawa M
    Biol Pharm Bull; 2016 May; 39(5):839-48. PubMed ID: 26887345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.
    Krieger SE; Zeisel MB; Davis C; Thumann C; Harris HJ; Schnober EK; Mee C; Soulier E; Royer C; Lambotin M; Grunert F; Dao Thi VL; Dreux M; Cosset FL; McKeating JA; Schuster C; Baumert TF
    Hepatology; 2010 Apr; 51(4):1144-57. PubMed ID: 20069648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of candidate virus receptors in human T lymphocytes prone or resistant to infection with patient-derived hepatitis C virus.
    Sarhan MA; Chen AY; Michalak TI
    PLoS One; 2013; 8(4):e62159. PubMed ID: 23626783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of intra- and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles.
    Ciesek S; Westhaus S; Wicht M; Wappler I; Henschen S; Sarrazin C; Hamdi N; Abdelaziz AI; Strassburg CP; Wedemeyer H; Manns MP; Pietschmann T; von Hahn T
    J Virol; 2011 Aug; 85(15):7613-21. PubMed ID: 21632765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Completion of the entire hepatitis C virus life cycle in genetically humanized mice.
    Dorner M; Horwitz JA; Donovan BM; Labitt RN; Budell WC; Friling T; Vogt A; Catanese MT; Satoh T; Kawai T; Akira S; Law M; Rice CM; Ploss A
    Nature; 2013 Sep; 501(7466):237-41. PubMed ID: 23903655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells.
    Mee CJ; Harris HJ; Farquhar MJ; Wilson G; Reynolds G; Davis C; van IJzendoorn SC; Balfe P; McKeating JA
    J Virol; 2009 Jun; 83(12):6211-21. PubMed ID: 19357163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The second extracellular loop dictates Occludin-mediated HCV entry.
    Liu S; Kuo W; Yang W; Liu W; Gibson GA; Dorko K; Watkins SC; Strom SC; Wang T
    Virology; 2010 Nov; 407(1):160-70. PubMed ID: 20822789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Splicing diversity of the human OCLN gene and its biological significance for hepatitis C virus entry.
    Kohaar I; Ploss A; Korol E; Mu K; Schoggins JW; O'Brien TR; Rice CM; Prokunina-Olsson L
    J Virol; 2010 Jul; 84(14):6987-94. PubMed ID: 20463075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes.
    Fofana I; Krieger SE; Grunert F; Glauben S; Xiao F; Fafi-Kremer S; Soulier E; Royer C; Thumann C; Mee CJ; McKeating JA; Dragic T; Pessaux P; Stoll-Keller F; Schuster C; Thompson J; Baumert TF
    Gastroenterology; 2010 Sep; 139(3):953-64, 964.e1-4. PubMed ID: 20685314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus induces CD81 and claudin-1 endocytosis.
    Farquhar MJ; Hu K; Harris HJ; Davis C; Brimacombe CL; Fletcher SJ; Baumert TF; Rappoport JZ; Balfe P; McKeating JA
    J Virol; 2012 Apr; 86(8):4305-16. PubMed ID: 22318146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolate-dependent use of claudins for cell entry by hepatitis C virus.
    Haid S; Grethe C; Dill MT; Heim M; Kaderali L; Pietschmann T
    Hepatology; 2014 Jan; 59(1):24-34. PubMed ID: 23775920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanding the Host Range of Hepatitis C Virus through Viral Adaptation.
    von Schaewen M; Dorner M; Hueging K; Foquet L; Gerges S; Hrebikova G; Heller B; Bitzegeio J; Doerrbecker J; Horwitz JA; Gerold G; Suerbaum S; Rice CM; Meuleman P; Pietschmann T; Ploss A
    mBio; 2016 Nov; 7(6):. PubMed ID: 27834208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A human claudin-1-derived peptide inhibits hepatitis C virus entry.
    Si Y; Liu S; Liu X; Jacobs JL; Cheng M; Niu Y; Jin Q; Wang T; Yang W
    Hepatology; 2012 Aug; 56(2):507-15. PubMed ID: 22378192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry.
    Harris HJ; Farquhar MJ; Mee CJ; Davis C; Reynolds GM; Jennings A; Hu K; Yuan F; Deng H; Hubscher SG; Han JH; Balfe P; McKeating JA
    J Virol; 2008 May; 82(10):5007-20. PubMed ID: 18337570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occludin-binding single-chain variable fragment and antigen-binding fragment antibodies prevent hepatitis C virus infection.
    Shimizu Y; Shinoda T; Shirasago Y; Kondoh M; Shinya N; Hanada K; Yagi K; Suzuki T; Wakita T; Kimura-Someya T; Shirouzu M; Fukasawa M
    FEBS Lett; 2021 Jan; 595(2):220-229. PubMed ID: 33113151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies.
    Ashfaq UA; Qasim M; Yousaf MZ; Awan MT; Jahan S
    J Transl Med; 2011 Nov; 9():194. PubMed ID: 22074322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulated Entry of Hepatitis C Virus into Hepatocytes.
    Miao Z; Xie Z; Miao J; Ran J; Feng Y; Xia X
    Viruses; 2017 May; 9(5):. PubMed ID: 28486435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD81-receptor associations--impact for hepatitis C virus entry and antiviral therapies.
    Zona L; Tawar RG; Zeisel MB; Xiao F; Schuster C; Lupberger J; Baumert TF
    Viruses; 2014 Feb; 6(2):875-92. PubMed ID: 24553110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.